FdaApplication

ANDA 218939

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASCENT PHARMACEUTICALS INC
application_typeANDA
approval_date2025-01-14

Products (3)

ProductActive ingredientStrengthDosage form
CARBIDOPA AND LEVODOPACARBIDOPA; LEVODOPA25MG;250MGTABLET;ORAL
CARBIDOPA AND LEVODOPACARBIDOPA; LEVODOPA10MG;100MGTABLET;ORAL
CARBIDOPA AND LEVODOPACARBIDOPA; LEVODOPA25MG;100MGTABLET;ORAL

3 products